All Stories

  1. Author Correction: Consensus Statement on the definition and classification of metabolic hyperferritinaemia
  2. Is obesity the next step in evolution through brain changes?
  3. Excess adiposity and iron‐deficient status in Colombian women of reproductive age
  4. Correction: The visceral adipose tissue bacterial microbiota provides a signature of obesity based on inferred metagenomic functions
  5. Metformin, Cognitive Function, and Changes in the Gut Microbiome
  6. Downregulated Adipose Tissue Expression of Browning Genes With Increased Environmental Temperatures
  7. The visceral adipose tissue bacterial microbiota provides a signature of obesity based on inferred metagenomic functions
  8. Obesity wars: may the smell be with you
  9. Plasma Lipidomics Profiles Highlight the Associations of the Dual Antioxidant/Pro-oxidant Molecules Sphingomyelin and Phosphatidylcholine with Subclinical Atherosclerosis in Patients with Type 1 Diabetes
  10. Gut Microbiota Composition and Functionality Are Associated With REM Sleep Duration and Continuous Glucose Levels
  11. The Longitudinal Changes in Subcutaneous Abdominal Tissue and Visceral Adipose Tissue Volumetries Are Associated with Iron Status
  12. Consensus Statement on the definition and classification of metabolic hyperferritinaemia
  13. The visceral adipose tissue bacterial microbiota provides a signature of obesity based on inferred metagenomic functions
  14. Soluble Transferrin Receptor, Antioxidant Status and Cardiometabolic Risk in Apparently Healthy Individuals
  15. DPP9 as a Potential Novel Mediator in Gastrointestinal Virus Infection
  16. The role of iron in host–microbiota crosstalk and its effects on systemic glucose metabolism
  17. Bidirectional relationships between the gut microbiome and sexual traits
  18. The Combined Partial Knockdown of CBS and MPST Genes Induces Inflammation, Impairs Adipocyte Function-Related Gene Expression and Disrupts Protein Persulfidation in Human Adipocytes
  19. Correction to: Whole-brain dynamics in aging: disruptions in functional connectivity and the role of the rich club
  20. Prognostic significance of the microbiome–adipose tissue axis in rectal cancer: protocol of a prospective observational study
  21. Serum ferritin and incident cardiometabolic diseases in Scottish adults
  22. Transdiagnostic Perspective of Impulsivity and Compulsivity in Obesity: From Cognitive Profile to Self-Reported Dimensions in Clinical Samples with and without Diabetes
  23. Neuregulin 4 Downregulation Induces Insulin Resistance in 3T3-L1 Adipocytes through Inflammation and Autophagic Degradation of GLUT4 Vesicles
  24. The effect of external stimulation on functional networks in the aging healthy human brain
  25. Novel Relationship Between Plasmalogen Lipid Signatures and Carnosine in Humans
  26. Whole-Brain Dynamics in Aging: Disruptions in Functional Connectivity and the Role of the Rich Club
  27. Is the jejunum the fulcrum of glucose metabolism?
  28. Gut microbiota steroid sexual dimorphism and its impact on gonadal steroids: influences of obesity and menopausal status
  29. Whole-brain dynamics in aging: disruptions in functional connectivity and the role of the rich club
  30. Low AMY1 Copy Number Is Cross‐Sectionally Associated to an Inflammation‐Related Lipidomics Signature in Overweight and Obese Individuals
  31. Comparative and functional analysis of plasma membrane-derived extracellular vesicles from obese vs. nonobese women
  32. The APOA1bp–SREBF–NOTCH axis is associated with reduced atherosclerosis risk in morbidly obese patients
  33. Plasma Phospholipids with Long‐Chain Polyunsaturated Fatty Acids and Dihydroceramides at the Crossroads of Iron Stores and Insulin Resistance
  34. Cytoskeletal transgelin 2 contributes to gender-dependent adipose tissue expandability and immune function
  35. Iron Status and Metabolically Unhealthy Obesity in Prepubertal Children
  36. Manipulation of gut intestinal fungy for the treatment of cardiovascular diseases
  37. Adipose TSHB in Humans and Serum TSH in Hypothyroid Rats Inform About Cellular Senescence
  38. Decreased TLR3 in Hyperplastic Adipose Tissue, Blood and Inflamed Adipocytes is Related to Metabolic Inflammation
  39. Hepatic iron content is independently associated with serum hepcidin levels in subjects with obesity
  40. Heme Biosynthetic Pathway is Functionally Linked to Adipogenesis via Mitochondrial Respiratory Activity
  41. MicroRNA-221-3p Regulates Angiopoietin-Like 8 (ANGPTL8) Expression in Adipocytes
  42. Adipose tissue: a new pituitary gland?
  43. The Gut Metagenome Changes in Parallel to Waist Circumference, Brain Iron Deposition, and Cognitive Function
  44. Dysregulation of Placental miRNA in Maternal Obesity Is Associated With Pre- and Postnatal Growth
  45. Correction: An increase in visceral fat is associated with a decrease in the taste and olfactory capacity
  46. HMOX1 as a marker of iron excess-induced adipose tissue dysfunction, affecting glucose uptake and respiratory capacity in human adipocytes
  47. Physiology and role of irisin in glucose homeostasis
  48. An increase in visceral fat is associated with a decrease in the taste and olfactory capacity
  49. Thyroid hormones induce browning of white fat
  50. Decreased lipid metabolism but increased FA biosynthesis are coupled with changes in liver microRNAs in obese subjects with NAFLD
  51. Modulation of SHBG binding to testosterone and estradiol by sex and morbid obesity
  52. miRNAs in cerebrospinal fluid identify patients with MS and specifically those with lipid-specific oligoclonal IgM bands
  53. Ferroportin mRNA is down-regulated in granulosa and cervical cells from infertile women
  54. Adipocyte lipopolysaccharide binding protein (LBP) is linked to a specific lipidomic signature
  55. Genome-wide DNA methylation pattern in visceral adipose tissue differentiates insulin-resistant from insulin-sensitive obese subjects
  56. Changes in blood microbiota profiles associated with liver fibrosis in obese patients: A pilot analysis
  57. Interaction Between Orexin-A and Sleep Quality in Females in Extreme Weight Conditions
  58. Decision Making Impairment: A Shared Vulnerability in Obesity, Gambling Disorder and Substance Use Disorders?
  59. Enduring Changes in Decision Making in Patients with Full Remission from Anorexia Nervosa
  60. Gestational diabetes is associated with changes in placental microbiota and microbiome
  61. Modulation of Irisin and Physical Activity on Executive Functions in Obesity and Morbid obesity
  62. Lipopolysaccharide-binding protein is a negative regulator of adipose tissue browning in mice and humans
  63. Genetic identification of thiosulfate sulfurtransferase as an adipocyte-expressed antidiabetic target in mice selected for leanness
  64. Genetic variations of the bitter taste receptor TAS2R38 are associated with obesity and impact on single immune traits
  65. Reduced circulating levels of sTWEAK are associated with NAFLD and may affect hepatocyte triglyceride accumulation
  66. Obesity Is Associated With Gene Expression and Imaging Markers of Iron Accumulation in Skeletal Muscle
  67. Orexin and sleep quality in anorexia nervosa: Clinical relevance and influence on treatment outcome
  68. Thyroid Hormone Receptors Are Differentially Expressed in Granulosa and Cervical Cells of Infertile Women
  69. A Lower Olfactory Capacity Is Related to Higher Circulating Concentrations of Endocannabinoid 2-Arachidonoylglycerol and Higher Body Mass Index in Women
  70. Metabolomics uncovers the role of adipose tissue PDXK in adipogenesis and systemic insulin sensitivity
  71. Erratum: Obesity changes the human gut mycobiome
  72. Bariatric surgery acutely changes the expression of inflammatory and lipogenic genes in obese adipose tissue
  73. Breath gas concentrations mirror exposure to sevoflurane and isopropyl alcohol in hospital environments in non-occupational conditions
  74. Serum Ferritin Relates to Carotid Intima-Media Thickness in Offspring of Fathers With Higher Serum Ferritin Levels
  75. Influence of Dietary Factors on Gut Microbiota
  76. Adipose tissue R2* signal is increased in subjects with obesity: A preliminary MRI study
  77. CISD1 in association with obesity‐associated dysfunctional adipogenesis in human visceral adipose tissue
  78. Lower serum osteocalcin concentrations are associated with brain microstructural changes and worse cognitive performance
  79. Gut Microbiota Interacts With Brain Microstructure and Function
  80. Lean mass, and not fat mass, is an independent determinant of carotid intima media thickness in obese subjects
  81. Changes in Body Composition in Anorexia Nervosa: Predictors of Recovery and Treatment Outcome
  82. Altered Circulating miRNA Expression Profile in Pregestational and Gestational Obesity
  83. Surgery-Induced Weight Loss Is Associated With the Downregulation of Genes Targeted by MicroRNAs in Adipose Tissue
  84. Physical activity in anorexia nervosa: How relevant is it to therapy response?
  85. Circulating hepcidin in type 2 diabetes: A multivariate analysis and double blind evaluation of metformin effects
  86. Obesity changes the human gut mycobiome
  87. Mechanisms Linking Glucose Homeostasis and Iron Metabolism Toward the Onset and Progression of Type 2 Diabetes
  88. Older type 2 diabetic patients are more likely to achieve glycaemic and cardiovascular risk factors targets than younger patients: analysis of a primary care database
  89. Circulating Betatrophin Levels Are Increased in Anorexia and Decreased in Morbidly Obese Women
  90. Proteasome Dysfunction Associated to Oxidative Stress and Proteotoxicity in Adipocytes Compromises Insulin Sensitivity in Human Obesity
  91. Circulating Hepcidin Is Independently Associated with Systolic Blood Pressure in Apparently Healthy Individuals
  92. Lipopolysaccharide binding protein is an adipokine involved in the resilience of the mouse adipocyte to inflammation
  93. Smell–taste dysfunctions in extreme weight/eating conditions: analysis of hormonal and psychological interactions
  94. Contrasting association of circulating sCD14 with insulin sensitivity in non‐obese and morbidly obese subjects
  95. Nicotinamide N-methyltransferase regulates hepatic nutrient metabolism through Sirt1 protein stabilization
  96. Modulation of Higher-Order Olfaction Components on Executive Functions in Humans
  97. Circulating Irisin Levels Are Positively Associated with Metabolic Risk Factors in Sedentary Subjects
  98. Serum 25-Hydroxyvitamin D and Adipose Tissue Vitamin D Receptor Gene Expression: Relationship With Obesity and Type 2 Diabetes
  99. PRDM16 sustains white fat gene expression profile in human adipocytes in direct relation with insulin action
  100. Effects of biliopancreatic diversion on diurnal leptin, insulin and free fatty acid levels
  101. Coxsackie and Adenovirus Receptor Is Increased in Adipose Tissue of Obese Subjects: A Role for Adenovirus Infection?
  102. DBC1 is involved in adipocyte inflammation and is a possible marker of human adipose tissue senescence
  103. Hypothalamic Damage Is Associated With Inflammatory Markers and Worse Cognitive Performance in Obese Subjects
  104. Nonalcoholic fatty liver disease and age are strong indicators for atherosclerosis in morbid obesity
  105. Response to Letter to the Editor
  106. Olive Oil and the Senescent Bone
  107. Cytosolic aconitase activity sustains adipogenic capacity of adipose tissue connecting iron metabolism and adipogenesis
  108. Carotid pulse wave velocity by magnetic resonance imaging is increased in middle-aged subjects with the metabolic syndrome
  109. Adipocyte Pseudohypoxia Suppresses Lipolysis and Facilitates Benign Adipose Tissue Expansion
  110. Adipose Tissue μ-Crystallin Is a Thyroid Hormone-Binding Protein Associated With Systemic Insulin Sensitivity
  111. Olive oil phenolic compounds decrease the postprandial inflammatory response by reducing postprandial plasma lipopolysaccharide levels
  112. Transducin-like enhancer of split 3 (TLE3) in adipose tissue is increased in situations characterized by decreased PPARγ gene expression
  113. Brain Iron Overload, Insulin Resistance, and Cognitive Performance in Obese Subjects: A Preliminary MRI Case-Control Study
  114. Moderate-Vigorous Physical Activity across Body Mass Index in Females: Moderating Effect of Endocannabinoids and Temperament
  115. Fine-tuned iron availability is essential to achieve optimal adipocyte differentiation and mitochondrial biogenesis
  116. Circulating irisin levels and coronary heart disease: association with future acute coronary syndrome and major adverse cardiovascular events
  117. Correction: The Rab11 Effector Protein FIP1 Regulates Adiponectin Trafficking and Secretion
  118. Effects of iron overload on chronic metabolic diseases
  119. Circulating Tryptase as a Marker for Subclinical Atherosclerosis in Obese Subjects
  120. Polymerase I and transcript release factor (PTRF) regulates adipocyte differentiation and determines adipose tissue expandability
  121. Relationship between eating styles and temperament in an Anorexia Nervosa, Healthy Control, and Morbid Obesity female sample
  122. Irisina: ¿transmisor de mensajes del Olimpo?
  123. The possible role of antimicrobial proteins in obesity-associated immunologic alterations
  124. Soluble TNFα-receptor 1 as a predictor of coronary calcifications in patients after long-term cure of Cushing’s syndrome
  125. Profiling of Circulating MicroRNAs Reveals Common MicroRNAs Linked to Type 2 Diabetes That Change With Insulin Sensitization
  126. The Trp64Arg β3-adrenergic receptor gene polymorphism is associated with endothelium-dependent vasodilatation
  127. Insulin Resistance Modulates Iron-Related Proteins in Adipose Tissue
  128. White fish reduces cardiovascular risk factors in patients with metabolic syndrome: The WISH-CARE study, a multicenter randomized clinical trial
  129. Alarmin high-mobility group B1 (HMGB1) is regulated in human adipocytes in insulin resistance and influences insulin secretion in β-cells
  130. Lactoferrin gene knockdown leads to similar effects to iron chelation in human adipocytes
  131. Irisin in humans: recent advances and questions for future research
  132. ITCH Deficiency Protects From Diet-Induced Obesity
  133. Association of Irisin with Fat Mass, Resting Energy Expenditure, and Daily Activity in Conditions of Extreme Body Mass Index
  134. Placental Sprouty 2 <b><i>(SPRY2)</i></b>: Relation to Placental Growth and Maternal Metabolic Status
  135. Multiple Hürthle cell adenomas in a patient with thyroid hormone resistance
  136. Inflammation in Adipose Tissue and Fatty Acid Anabolism: When Enough is Enough!
  137. Human omental and subcutaneous adipose tissue exhibit specific lipidomic signatures
  138. Irisin, the metabolic syndrome and follistatin in humans
  139. Loss of Control over Eating: A Description of the Eating Disorder/Obesity Spectrum in Women
  140. Adaptive Changes of the Insig1/SREBP1/SCD1 Set Point Help Adipose Tissue to Cope With Increased Storage Demands of Obesity
  141. Changes in Circulating MicroRNAs Are Associated With Childhood Obesity
  142. Serum lipopolysaccharide-binding protein as a marker of atherosclerosis
  143. CIDEC/FSP27 and PLIN1 gene expression run in parallel to mitochondrial genes in human adipose tissue, both increasing after weight loss
  144. Inflammation and insulin resistance exert dual effects on adipose tissue tumor protein 53 expression
  145. A role for adipocyte-derived lipopolysaccharide-binding protein in inflammation- and obesity-associated adipose tissue dysfunction
  146. Study of lactoferrin gene expression in human and mouse adipose tissue, human preadipocytes and mouse 3T3-L1 fibroblasts. Association with adipogenic and inflammatory markers
  147. Modulation of the Endocannabinoids N-Arachidonoylethanolamine (AEA) and 2-Arachidonoylglycerol (2-AG) on Executive Functions in Humans
  148. Decreased RB1 mRNA, Protein, and Activity Reflect Obesity-Induced Altered Adipogenic Capacity in Human Adipose Tissue
  149. Targeting the Circulating MicroRNA Signature of Obesity
  150. Common Genetic Variants of Surfactant Protein-D (SP-D) Are Associated with Type 2 Diabetes
  151. Irisin Is Expressed and Produced by Human Muscle and Adipose Tissue in Association With Obesity and Insulin Resistance
  152. Iron and Obesity Status-Associated Insulin Resistance Influence Circulating Fibroblast-Growth Factor-23 Concentrations
  153. Erratum to: Targeting the association of calgranulin B (S100A9) with insulin resistance and type 2 diabetes
  154. Thyroid hormone receptor alpha gene variants increase the risk of developing obesity and show gene–diet interactions
  155. Liver, but not adipose tissue PEDF gene expression is associated with insulin resistance
  156. Co-occurrence of non-suicidal self-injury and impulsivity in extreme weight conditions
  157. Phosphorylated S6K1 (Thr389) is a molecular adipose tissue marker of altered glucose tolerance
  158. FABP4 Dynamics in Obesity: Discrepancies in Adipose Tissue and Liver Expression Regarding Circulating Plasma Levels
  159. A Mediterranean Diet Enriched with Olive Oil Is Associated with Higher Serum Total Osteocalcin Levels in Elderly Men at High Cardiovascular Risk
  160. Lucha por sobrevivir, diabetes tipo 2 y obesidad. Respuesta del autor
  161. The association of biomarkers of iron status with mortality in US adults
  162. Erratum to: The gut microbiota profile is associated with insulin action in humans
  163. Executive Functions Profile in Extreme Eating/Weight Conditions: From Anorexia Nervosa to Obesity
  164. Serum and urinary concentrations of calprotectin as markers of insulin resistance and type 2 diabetes
  165. The gut microbiota profile is associated with insulin action in humans
  166. Breast Cancer 1 (BrCa1) May Be behind Decreased Lipogenesis in Adipose Tissue from Obese Subjects
  167. Back to past leeches: repeated phlebotomies and cardiovascular risk
  168. Circulating Zonulin, a Marker of Intestinal Permeability, Is Increased in Association with Obesity-Associated Insulin Resistance
  169. Lifetime Obesity in Patients with Eating Disorders: Increasing Prevalence, Clinical and Personality Correlates
  170. Lucha por sobrevivir, diabetes tipo 2 y obesidad
  171. Peroxisome Proliferator-Activated Receptor  -Dependent Regulation of Lipolytic Nodes and Metabolic Flexibility
  172. Thel-α-Lysophosphatidylinositol/GPR55System and Its Potential Role in Human Obesity
  173. Uncovering Suitable Reference Proteins for Expression Studies in Human Adipose Tissue with Relevance to Obesity
  174. Attenuated metabolism is a hallmark of obesity as revealed by comparative proteomic analysis of human omental adipose tissue
  175. Multivariate Methods for the Integration and Visualization of Omics Data
  176. Circulating lipopolysaccharide-binding protein (LBP) as a marker of obesity-related insulin resistance
  177. Total and undercarboxylated osteocalcin predict changes in insulin sensitivity and β cell function in elderly men at high cardiovascular risk
  178. The postprandial inflammatory response after ingestion of heated oils in obese persons is reduced by the presence of phenol compounds
  179. Plasma PTX3 protein levels inversely correlate with insulin secretion and obesity, whereas visceral adipose tissue PTX3 gene expression is increased in obesity
  180. Proadipogenic effects of lactoferrin in human subcutaneous and visceral preadipocytes
  181. Innate immunity, insulin resistance and type 2 diabetes
  182. DecreasedSTAMP2Expression in Association with Visceral Adipose Tissue Dysfunction
  183. Structural damage in diabetic nephropathy is associated with TNF-α system activity
  184. Adipocyte Differentiation
  185. Mirror extreme BMI phenotypes associated with gene dosage at the chromosome 16p11.2 locus
  186. Circulating Omentin as a Novel Biomarker of Endothelial Dysfunction
  187. CD14 Modulates Inflammation-Driven Insulin Resistance
  188. Increased Levels of Calprotectin in Obesity Are Related to Macrophage Content: Impact on Inflammation and Effect of Weight Loss
  189. Decreased Serum Creatinine Concentration Is Associated With Short Telomeres of Adipose Tissue Cells
  190. Osteocalcin: a new link between bone and energy metabolism. Some evolutionary clues
  191. Role of diabetes- and obesity-related protein in the regulation of osteoblast differentiation
  192. Genetic variation near IRS1 associates with reduced adiposity and an impaired metabolic profile
  193. Type I iodothyronine 5′-deiodinase mRNA and activity is increased in adipose tissue of obese subjects
  194. The alarm secretory leukocyte protease inhibitor increases with progressive metabolic dysfunction
  195. Antimicrobial-Sensing Proteins in Obesity and Type 2 Diabetes
  196. OCT1 Expression in Adipocytes Could Contribute to Increased Metformin Action in Obese Subjects
  197. Circulating Pigment Epithelium-Derived Factor Levels Are Associated with Insulin Resistance and Decrease after Weight Loss
  198. La resistencia a la insulina como mecanismo de adaptación durante la evolución humana
  199. Secreted frizzled-related protein 1 regulates adipose tissue expansion and is dysregulated in severe obesity
  200. Transferrin receptor-1 gene polymorphisms are associated with type 2 diabetes
  201. Olive oil and health: Summary of the II international conference on olive oil and health consensus report, Jaén and Córdoba (Spain) 2008
  202. The Decrease of Serum Levels of Human Neutrophil Alpha-Defensins Parallels with the Surgery-Induced Amelioration of NASH in Obesity
  203. Extracellular Fatty Acid Synthase: A Possible Surrogate Biomarker of Insulin Resistance
  204. Telomere length of subcutaneous adipose tissue cells is shorter in obese and formerly obese subjects
  205. Circulating osteocalcin concentrations are associated with parameters of liver fat infiltration and increase in parallel to decreased liver enzymes after weight loss
  206. Environmental and Genetic Factors Influence the Relationship Between Circulating IL‐10 and Obesity Phenotypes
  207. Fat Overload Induces Changes in Circulating Lactoferrin That Are Associated With Postprandial Lipemia and Oxidative Stress in Severely Obese Subjects
  208. Resistance Training Improves Cardiovascular Risk Factors in Obese Women Despite a Significative Decrease in Serum Adiponectin Levels
  209. MiRNA Expression Profile of Human Subcutaneous Adipose and during Adipocyte Differentiation
  210. Characterization of Herpes Virus Entry Mediator as a Factor Linked to Obesity
  211. LIPOPOLYSACCHARIDE-BINDING PROTEIN AND SOLUBLE CD14 IN THE VITREOUS FLUID OF PATIENTS WITH PROLIFERATIVE DIABETIC RETINOPATHY
  212. Surfactant Protein D, a Marker of Lung Innate Immunity, Is Positively Associated With Insulin Sensitivity
  213. The Gene Expression of the Main Lipogenic Enzymes is Downregulated in Visceral Adipose Tissue of Obese Subjects
  214. Circulating bactericidal/permeability-increasing protein (BPI) is associated with serum lipids and endothelial function
  215. Study of caveolin-1 gene expression in whole adipose tissue and its subfractions and during differentiation of human adipocytes
  216. Thyroid hormone responsive Spot 14 increases during differentiation of human adipocytes and its expression is down-regulated in obese subjects
  217. Metabolic endotoxemia and saturated fat contribute to circulating NGAL concentrations in subjects with insulin resistance
  218. Subcutaneous Fat Shows Higher Thyroid Hormone Receptor‐α1 Gene Expression Than Omental Fat
  219. Deleterious Effects of Glucocorticoid Replacement on Bone in Women After Long‐Term Remission of Cushing's Syndrome
  220. Complement Factor H Is Expressed in Adipose Tissue in Association With Insulin Resistance
  221. Decreased Circulating Lactoferrin in Insulin Resistance and Altered Glucose Tolerance as a Possible Marker of Neutrophil Dysfunction in Type 2 Diabetes
  222. A Link between Bone Mineral Density and Serum Adiponectin and Visfatin Levels in Acromegaly
  223. LIGHT is associated with hypertriglyceridemia in obese subjects and increased cytokine secretion from cultured human adipocytes
  224. Increase in Plasma Endotoxin Concentrations and the Expression of Toll-Like Receptors and Suppressor of Cytokine Signaling-3 in Mononuclear Cells After a High-Fat, High-Carbohydrate Meal
  225. Persistent Body Fat Mass and Inflammatory Marker Increases after Long-Term Cure of Cushing’s Syndrome
  226. Val1483Ile in FASN Gene Is Linked to Central Obesity and Insulin Sensitivity in Adult White Men
  227. Lactoferrin increases 172ThrAMPK phosphorylation and insulin-induced p473SerAKT while impairing adipocyte differentiation
  228. The association of biomarkers of iron status with peripheral arterial disease in US adults
  229. Grape-seed procyanidins modulate inflammation on human differentiated adipocytes in vitro
  230. Tackling the human adipose tissue proteome to gain insight into obesity and related pathologies
  231. Low Serum Mannose-Binding Lectin as a Risk Factor for New Onset Diabetes Mellitus After Renal Transplantation
  232. Circulating soluble transferrin receptor concentration decreases after exercise-induced improvement of insulin sensitivity in obese individuals
  233. Study of the proinflammatory role of human differentiated omental adipocytes
  234. Adipocyte Fatty Acid‐binding Protein as a Determinant of Insulin Sensitivity in Morbid‐obese Women
  235. Study of Circulating Prohepcidin in Association with Insulin Sensitivity and Changing Iron Stores
  236. Fatty Acid Synthase: Association with Insulin Resistance, Type 2 Diabetes, and Cancer
  237. Differential Proteomics of Omental and Subcutaneous Adipose Tissue Reflects Their Unalike Biochemical and Metabolic Properties
  238. The Relationship of Serum Osteocalcin Concentration to Insulin Secretion, Sensitivity, and Disposal with Hypocaloric Diet and Resistance Training
  239. AMPK-sensed cellular energy state regulates the release of extracellular Fatty Acid Synthase
  240. Circulating soluble CD36 is associated with glucose metabolism and interleukin-6 in glucose-intolerant men
  241. Joint analysis of individual participants’ data from 17 studies on the association of theIL6variant -174G>C with circulating glucose levels, interleukin-6 levels, and body mass index
  242. Maternal glucose tolerance status influences the risk of macrosomia in male but not in female fetuses
  243. Gender dimorphism in body composition abnormalities in acromegaly: males are more affected than females
  244. The nuclear receptor coactivator AIB3 is a modulator of HOMA β‐cell function in nondiabetic children
  245. Association of ADIPOR2 With Liver Function Tests in Type 2 Diabetic Subjects
  246. La excreción urinaria de interleucina 6 refleja la presión arterial sistólica media durante 24 h en pacientes con diabetes mellitus tipo 2
  247. The tyrosine kinase receptor HER2 (erbB‐2): From oncogenesis to adipogenesis
  248. Salicylates Increase Insulin Secretion in Healthy Obese Subjects
  249. Circulating Retinol-Binding Protein-4 Concentration Might Reflect Insulin Resistance–Associated Iron Overload
  250. Circulating Surfactant Protein A (SP-A), a Marker of Lung Injury, Is Associated With Insulin Resistance
  251. Human serum levels of fetal antigen 1 (FA1/Dlk1) increase with obesity, are negatively associated with insulin sensitivity and modulate inflammation in vitro
  252. Hiponatremia sintomática inducida por citalopram y escitalopram
  253. Insulin Resistance Is Associated With Decreased Circulating Mannan-Binding Lectin Concentrations in Women With Polycystic Ovary Syndrome
  254. Association of Circulating Lactoferrin Concentration and 2 Nonsynonymous LTF Gene Polymorphisms with Dyslipidemia in Men Depends on Glucose-Tolerance Status
  255. Insulin sensitivity and resistin levels in gestational diabetes mellitus and after parturition
  256. Bloodletting Ameliorates Insulin Sensitivity and Secretion in Parallel to Reducing Liver Iron in Carriers of HFE Gene Mutations
  257. Innate immunity, insulin resistance and type 2 diabetes
  258. Human subcutaneous adipose tissue LPIN1 expression in obesity, type 2 diabetes mellitus, and human immunodeficiency virus--associated lipodystrophy syndrome
  259. Different TNFα expression elicited by glucose in monocytes from type 2 diabetes mellitus patients
  260. Adipose Tissue Expression of the Glycerol Channel Aquaporin-7 Gene Is Altered in Severe Obesity But Not in Type 2 Diabetes
  261. Circulating Retinol-Binding Protein-4, Insulin Sensitivity, Insulin Secretion, and Insulin Disposition Index in Obese and Nonobese Subjects
  262. Circulating Retinol-Binding Protein-4, Insulin Sensitivity, Insulin Secretion, and Insulin Disposition Index in Obese and Nonobese Subjects
  263. Insulin-Like Growth Factor Binding Protein–Related Protein 1 (IGFBP-rP1/MAC25) Is Linked to Endothelial-Dependent Vasodilation in High-Ferritin Type 2 Diabetes
  264. Massive Weight Loss Decreases Corticosteroid-Binding Globulin Levels and Increases Free Cortisol in Healthy Obese Patients
  265. Alpha Defensins 1, 2, and 3
  266. Complicaciones nutricionales después del tratamiento quirúrgico de la obesidad: ¿qué ocurre en el bypass gástrico?
  267. Serum Interleukin-6 Correlates With Endothelial Dysfunction in Healthy Men Independently of Insulin Sensitivity
  268. Soluble TNF-α receptor 2 produced by alternative splicing is paradoxically associated with markers of liver injury
  269. Circulating Visfatin Is Associated With Parameters of Iron Metabolism in Subjects With Altered Glucose Tolerance
  270. Monocyte Chemoattractant Protein‐1 in Obesity and Type 2 Diabetes. Insulin Sensitivity Study
  271. Effect of Massive Weight Loss on Inflammatory Adipocytokines and the Innate Immune System in Morbidly Obese Women
  272. Apoplejía hipofisaria. Algunas consideraciones sobre su concepto y manejo
  273. Burden of Infection and Fat Mass in Healthy Middle‐aged Men
  274. Sex-specific, independent associations of insulin resistance with erythrocyte sedimentation rate in apparently healthy subjects
  275. An alternatively spliced soluble TNF-α receptor is associated with metabolic disorders A replication study
  276. IL6 Gene Promoter Polymorphisms and Type 2 Diabetes
  277. Serum Visfatin Increases With Progressive β-Cell Deterioration
  278. Thyroid Function Is Intrinsically Linked to Insulin Sensitivity and Endothelium-Dependent Vasodilation in Healthy Euthyroid Subjects
  279. Etiología del síndrome del ovario poliquístico
  280. Protection from inflammatory disease in insulin resistance: the role of mannan-binding lectin
  281. Insulin Resistance Is Associated With Increased Serum Concentration of IGF-Binding Protein–Related Protein 1 (IGFBP-rP1/MAC25)
  282. The ACAA-insertion/deletion polymorphism at the 3′ UTR of the IGF-II receptor gene is associated with type 2 diabetes and surrogate markers of insulin resistance
  283. Divergent Relationships Among Soluble Tumor Necrosis Factor-α Receptors 1 and 2, Insulin Resistance, and Endothelial Function
  284. Polymorphisms in the interleukin‐6 receptor gene are associated with body mass index and with characteristics of the metabolic syndrome
  285. An alternative spliced variant of circulating soluble tumor necrosis factor-α receptor-2 is paradoxically associated with insulin action
  286. Expression of TWEAK and its receptor Fn14 in human subcutaneous adipose tissue. Relationship with other inflammatory cytokines in obesity
  287. Genetic Predispositions to Low-Grade Inflammation and Type 2 Diabetes
  288. The tumour necrosis factor (TNF)‐α−308GA promoter polymorphism is related to prenatal growth and postnatal insulin resistance
  289. Correction
  290. Body mass index has a greater impact on pregnancy outcomes than gestational hyperglycaemia
  291. Circulating IL-18 concentration is associated with insulin sensitivity and glucose tolerance through increased fat-free mass
  292. A Polymorphism in the 3′ Untranslated Region of the Gene for Tumor Necrosis Factor Receptor 2 Modulates Reporter Gene Expression
  293. Corticosteroid-binding globulin affects the relationship between circulating adiponectin and cortisol in men and women
  294. Tumour necrosis factor receptors (TNFRs) in Type 2 diabetes. Analysis of soluble plasma fractions and genetic variations of TNFR2 gene in a case‐control study
  295. Lowering of blood pressure leads to decreased circulating interleukin-6 in hypertensive subjects
  296. Circulating Adiponectin and Plasma Fatty Acid Profile
  297. Differential regulation of insulin action and tumor necrosis factor α system activity by metformin
  298. Dyslipidemia and inflammation: an evolutionary conserved mechanism
  299. An Inflammation Score Is Better Associated with Basal than Stimulated Surrogate Indexes of Insulin Resistance
  300. Chronic Inflammatory Hypothesis in the Metabolic Syndrome
  301. Opposite relationship between circulating soluble CD14 concentration and endothelial function in diabetic and nondiabetic subjects
  302. Mannose-Binding Lectin Gene Polymorphisms Are Associated with Gestational Diabetes Mellitus
  303. Both intrauterine growth restriction and postnatal growth influence childhood serum concentrations of adiponectin
  304. Adiponectin is independently associated with glycosylated haemoglobin
  305. Identification and characterization of a novel spliced variant that encodes human soluble tumor necrosis factor receptor 2
  306. Smoking, fat mass and activation of the tumor necrosis factor-α pathway
  307. Diagnóstico tardío en la rotura traumática del páncreas y el conducto pancreático
  308. Insulin Resistance, Inflammation, and Serum Fatty Acid Composition
  309. CD14 Monocyte Receptor, Involved in the Inflammatory Cascade, and Insulin Sensitivity
  310. A polymorphism in the promoter of the tumor necrosis factor-α gene (−308) is associated with coronary heart disease in type 2 diabetic patients
  311. Evolución ponderal en la población de Girona, 1989-1999
  312. Blood Letting in High-Ferritin Type 2 Diabetes
  313. Serum Corticosteroid-Binding Globulin Concentration and Insulin Resistance Syndrome: A Population Study
  314. Short-term mortality of myocardial infarction patients with diabetes or hyperglycaemia during admission
  315. Pro12Ala Substitution in the Peroxisome Proliferator-Activated Receptor-Gamma Is Associated with Increased Leptin Levels in Women with Type-2 Diabetes mellitus
  316. Study of the effect of changing glucose, insulin, and insulin-like growth factor-I levels on serum corticosteroid binding globulin in lean, obese, and obese subjects with glucose intolerance
  317. Comments to: Yudkin J, Panahloo A, Stenhouwer C et al. (2000) The influence of improved glycaemic control with insulin and sulphonylureas on acute phase and endothelial markets in Type II diabetic subjects. Diabetologia 43: 1099-1106
  318. Interleukin-6 Gene Polymorphism and Lipid Abnormalities in Healthy Subjects
  319. The insulin resistance syndrome and the binding capacity of cortisol binding globulin (CBG) in men and women
  320. Insulin response to intravenous glucose correlates with plasma levels of the tumor necrosis factor receptor-1.
  321. Tumor necrosis factor system activity is associated with insulin resistance and dyslipidemia in myotonic dystrophy.
  322. Plasma oestrone‐fatty acid ester levels are correlated with body fat mass in humans
  323. Plasma levels of the soluble fraction of tumor necrosis factor receptor 2 and insulin resistance.
  324. β3‐adrenoreceptor gene polymorphism and leptin. Lack of relationship in type 2 diabetic patients
  325. Leptin is involved in gender‐related differences in insulin sensitivity
  326. Study of glucose tolerance in consecutive patients harbouring incidental adrenal tumours
  327. The TNF-β Gene Nco I Polymorphism Is Not Associated with Hypertriglyceridemia or Insulin Resistance in Lean and Obese Subjects
  328. Primary Hypothyroidism and Concomitant Bilateral Ovarian Masses
  329. Selenium deficiency, reversible cardiomyopathy and short-term intravenous feeding
  330. Study on growth hormone and insulin secretion in myotonic dystrophy
  331. Giant intrasellar aneurysm presenting with panhypopituitarism and subarachnoid hemorrhage: case report and literature review
  332. Pre-Clinical Cushing’s Syndrome: Report of Three Cases and Literature Review
  333. Tuberculous Addison's disease. Utility of CT in diagnosis and follow-up
  334. Hemifacial spasm and hypothyroidism
  335. GH secretion status in myotonic dystrophy